MERTK and colorectal cancer: A lipid nanoparticle platform encapsulating siRNA for the phagocytic receptor MerTK (siMerTK) was found to selectively inhibit MerTK-mediated efferocytosis and exert therapeutic effects in both liver and peritoneal metastasis models of colorectal cancers.